Global reach Sequentia Biotech serves clients in 63 countries and has a robust track record with over 700 bioinformatics projects, indicating strong international sales potential and opportunities for cross-border collaborations, licensing, or managed services.

Strategic partnerships Recent integrations and partnerships, including Platomics GmbH and acquisitions like BVI Invest, suggest a readiness to expand capabilities through ecosystem alliances, offering high-value joint solutions and co-sell opportunities.

Funding momentum With a recent €10 million equity investment and multi-year funding, there is budget flexibility for expanding SaaS analytics offerings, clinical and industrial bioinformatics solutions, and ramping up enterprise-grade deployments.

Micka platform MICK and related omics platforms demonstrate a focus on microbiome data in health, presenting opportunities to upsell data integration, consulting, and turnkey analytics for hospitals, clinics, and research institutions pursuing microbiome-driven therapies.

Publications and credibility A strong publication record and high H-index bolster credibility for selling advanced analytics, diagnostic tools, and research collaborations to academic labs, biotech startups, and pharma companies seeking proven, publication-backed solutions.